Skip to content

Tolerance of Healthy Infants Fed Infant Formulas

Tolerance of Healthy Infants Fed Infant Formulas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02401217
Enrollment
126
Registered
2015-03-27
Start date
2015-04-30
Completion date
2015-09-30
Last updated
2016-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Tolerance

Brief summary

The primary objective of this study is to assess the comparative gastrointestinal tolerance of normal term infants to two experimental milk-based powdered formulas compared with a standard milk-based powdered formula.

Interventions

OTHERPhase 1- Arm 1 Infant Formula

Powder infant formula

OTHERPhase 2- Arm 2 Infant Formula

Powder infant formula

OTHERPhase 2- Arm 3 Infant Formula

Powder infant formula

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 30 Days
Healthy volunteers
No

Inclusion criteria

* Singleton from a full term birth with a gestational age of 37-42 weeks. * Birth weight was \> 2490 g (\ 5 lbs 8 oz). * Age between 0 and 30 days at enrollment. * Agreement to discontinue the use of medications (including over the counter \[OTC\], such as Mylicon® for gas), home remedies, herbal preparations or rehydration fluids that might affect GI tolerance for the duration of the study. * Intention to feed the infant the study product as the sole source of nutrition for the duration of the study. * Intention not to administer vitamin (other than Vitamin D) or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study. * Voluntarily signed and dated an informed consent form (ICF) approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study.

Exclusion criteria

* An adverse maternal, fetal or infant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development. * Infant treated with antibiotics. * Participation in another study that has not been approved as a concomitant study by AN.

Design outcomes

Primary

MeasureTime frameDescription
Stool consistency measured by Mean Rank Stool Consistency (MRSC) using parent reported diariesChange from Study Day 1 to Study Day 15MRSC will be calculated from data recorded on daily stool records during the study. Stool consistencies will be assigned the following: 1=watery, 2=loose/mushy, 3=soft, 4=formed, 5=hard.

Secondary

MeasureTime frameDescription
Mean Percentage of stools representing each stool consistency and color using parent reported diariesChange from Study Day 1 to Study Day 15Mean percentage of each recorded stool consistency (watery, loose/mushy, soft, formed, hard) and stool color (yellow, brown, green, black) will be calculated for each infant and then used to calculate for each group from daily data recorded on daily stool records during the study.
Mean predominant stool consistency and color measured using parent reported diariesChange from Study Day 1 to Study Day 15Mean predominant stool consistency and color for each infant calculated from data recorded on daily stool records during the study will be used to calculate the mean predominant stool consistency and color for each group.
Average number of stools per day measured using parent reported diariesChange from Study Day 1 to Study Day 15Average number of stools/day will be calculated for each group from data recorded on daily stool records during the study.
Mean percentages of feedings associated with spit-up and/or vomit measured using parent reported diaries.Change from Study Day 1 to Study Day 15Mean percentages of feedings associated with spit-up and/or vomiting will be calculated for each group from data recorded on daily formula intake records during the study.
Parental responses to Formula Satisfaction and Infant Feeding and Stool Patterns QuestionnairesChange from Study Day 1 to Study Day 15Parental responses to individual question on the Formula Satisfaction Questionnaire will be calculated from data recorded on the questionnaire at Study Day 15
Parental assessment of infant feeding and stool patterns measured by the Infant Feeding and Stool Patterns Questionnaire.Change from Study Day 1 to Study Day 15Parental responses to individual question on the Feeding and Stool Patterns Questionnaire will be calculated from data recorded on the questionnaire at Study Day 15.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026